Dossier
trade probe
Coverage of trade probe in the Nexus archive.
- Why is the US targeting Germany's drug industry?
A new trade probe by the US is reigniting a dispute over cost distribution for medical innovation, with Washington claiming Germany benefits from lower drug prices while US patients cover higher costs.